All Episodes
Keeping Current — 632 episodes · page 7 of 7
Managing Patients With Inflammatory Diseases During the COVID-19 Pandemic
Unmet Needs in Familial Hypercholesterolemia Management Today
Recognizing Familial Hypercholesterolemia and What to Do Next
Managing Patients With Multiple Myeloma in the COVID-19 Environment
COVID-19: Respiratory and Cardiovascular Considerations
Managing Patients With SLE During the COVID-19 Pandemic
The Molecular Tumor Board in Action: Understanding the Role and Benefit Through Real-World Case Studies
Diabetology and Cardiology in Dialogue -- What is State-of-the-Art for Best Diabetes Care?
COVID-19 Management: Practice Essentials and Answers From the Experts
Optimizing Treatment in Patients With Moderate to Severe Psoriasis
Evaluation of Biologic Therapies in Psoriasis: What Is the Evidence Beyond Clinical Trials?
Time to Reassess Biomarkers in Multiple Myeloma?
COVID-19 Pandemic: Further Implications for Diabetes Care
Early Intervention in COPD: Are 2 Bronchodilators Better Than 1?
COVID-19 and Mental Health: Taking Positive Action in This New Environment
COVID-19 and Comorbidities: Unhappy Bedfellows
COVID-19 Pandemic: The Implications for Diabetes Care
The Evolution of Knowledge on COVID-19 and Multiple Sclerosis
Moving Towards Routine Use of Comprehensive Genomic Profiling Across Oncology: From Clinical Rationale to Practical Application
What You Need to Know About CAR T-Cell Therapy in Multiple Myeloma: A Deep Dive
What You Need to Know About CAR T-Cell Therapy in NHL: A Deep Dive
What We Currently Know About COVID-19 and MS
The AxSpA Spectrum of Diseases: How to Diagnose and Manage Patients in Clinical Practice?
Patients With ND AML Unfit for Intensive Chemotherapy: Tailoring Treatment
COPD: Patient Selection Based on GOLD Guidance and Response to Therapy
CAR T-Cell Therapy in Non-Hodgkin Lymphoma and Multiple Myeloma: A Clinical Update
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice
Idiopathic Pulmonary Fibrosis: The Right Treatments at the Right Time
Approaching a New Era in the Management of Progressive Fibrosing ILDs
How Can We Meet the Treatment Needs of Patients With Systemic Sclerosis-Interstitial Lung Disease?
Working Together to Diagnose Idiopathic Pulmonary Fibrosis
The Progressive Phenotype of Non-IPF ILD: Clinical Relevance and Identification